Guardian Pharmacy Services (GRDN) to Release Earnings on Tuesday

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) will likely be releasing its earnings data before the market opens on Tuesday, February 11th. Analysts expect Guardian Pharmacy Services to post earnings of $0.20 per share for the quarter. Guardian Pharmacy Services has set its FY 2024 guidance at EPS.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. On average, analysts expect Guardian Pharmacy Services to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Guardian Pharmacy Services Trading Down 4.5 %

Shares of GRDN traded down $1.00 during trading hours on Friday, reaching $21.24. 52,489 shares of the company's stock traded hands, compared to its average volume of 81,224. Guardian Pharmacy Services has a 12 month low of $14.16 and a 12 month high of $25.74. The firm's 50 day simple moving average is $22.03.

Insiders Place Their Bets

In other Guardian Pharmacy Services news, Director Steven D. Cosler purchased 7,000 shares of the business's stock in a transaction on Tuesday, November 19th. The stock was acquired at an average cost of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the transaction, the director now directly owns 17,713 shares in the company, valued at approximately $375,869.86. This represents a 65.34 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Analyst Ratings Changes

Several brokerages have issued reports on GRDN. Truist Financial lifted their target price on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a "buy" rating in a research report on Friday, November 15th. Raymond James began coverage on shares of Guardian Pharmacy Services in a report on Monday, October 21st. They set an "outperform" rating and a $21.00 price objective for the company. Finally, Stephens began coverage on Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an "overweight" rating and a $21.00 target price on the stock.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.